rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2009-11-2
|
pubmed:abstractText |
To demonstrate the theoretical feasibility of [(11)C]acetate PET/CT in delineating the malignant intraprostatic lesions (IPL's) in prostate cancer and to use the data in external beam radiotherapy to boost the biologically defined target volume (BTV).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1879-0887
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
93
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
234-40
|
pubmed:meshHeading |
pubmed-meshheading:19766336-Acetates,
pubmed-meshheading:19766336-Carbon,
pubmed-meshheading:19766336-Carbon Radioisotopes,
pubmed-meshheading:19766336-Humans,
pubmed-meshheading:19766336-Male,
pubmed-meshheading:19766336-Positron-Emission Tomography,
pubmed-meshheading:19766336-Prostatic Neoplasms,
pubmed-meshheading:19766336-Radiotherapy, Intensity-Modulated,
pubmed-meshheading:19766336-Radiotherapy Dosage,
pubmed-meshheading:19766336-Tomography, X-Ray Computed
|
pubmed:year |
2009
|
pubmed:articleTitle |
Carbon-11 acetate PET/CT based dose escalated IMRT in prostate cancer.
|
pubmed:affiliation |
Department of Oncology and Radiotherapy, Turku University Hospital, Turku, Finland. jan.seppala@tyks.fi
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|